Structural Determinants for the Interactions of Chemically Modified Nucleic Acids with the Stabilin-2 Clearance Receptor
Gaus H, Miller CM, Seth PP, Harris EN. Biochemistry. 2018 Apr 10;57(14):2061-2064. PubMed
saRNAdb: Resource of small activating RNAs for up-regulating the gene expression
Dar SA, Kumar M. J Mol Biol. 2018 Apr 3. pii: S0022-2836(18)30172-4. PubMed
Estimated number of off-target candidate sites for antisense oligonucleotides in human mRNA sequences
Yoshida T, Naito Y, Sasaki K, Uchida E, Sato Y, Naito M, Kawanishi T, Obika S, Inoue T. Genes Cells. 2018 Apr 18. PubMed
Modulation of Tau Isoforms Imbalance Precludes Tau Pathology and Cognitive Decline in a Mouse Model of Tauopathy
Espíndola SL, Damianich A, Alvarez RJ, Sartor M, Belforte JE, Ferrario JE, Gallo JM, Avale ME. Cell Rep. 2018 Apr 17;23(3):709-715. PubMed
An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance
Bester AC, Lee JD, Chavez A, Lee YR, Nachmani D, Vora S, Victor J, Sauvageau M, Monteleone E, Rinn JL, Provero P, Church GM, Clohessy JG, Pandolfi PP. Cell. 2018 Apr 19;173(3):649-664.e20. PubMed
Measuring DNA hybridization using fluorescent DNA-stabilized silver clusters to investigate mismatch effects on therapeutic oligonucleotides
de Bruin D, Bossert N, Aartsma-Rus A, Bouwmeester D. J Nanobiotechnology. 2018 Apr 6;16(1):37. PubMed
RNA-Targeted Therapeutics
Crooke ST, Witztum JL, Bennett CF, Baker BF. Cell Metab. 2018 Apr 3;27(4):714-739. PubMed
Aptamer chemistry
Röthlisberger P, Hollenstein M. Adv Drug Deliv Rev. 2018 Apr 4. PubMed
Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics
Urbanski LM, Leclair N, Anczuków O. Wiley Interdiscip Rev RNA. 2018 Apr 25:e1476. PubMed
Nucleic acids delivering nucleic acids
Catuogno S, Esposito CL, Condorelli G, de Franciscis V. Adv Drug Deliv Rev. 2018 Apr 6. pii: S0169-409X(18)30058-9 PubMed
